4-(2-chloro-ethyl)-2,6-dimethyl-morpholine | 147847-86-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-(2-chloro-ethyl)-2,6-dimethyl-morpholine
• 英文别名: 4-(2-Chlor-aethyl)-2,6-dimethyl-morpholin；4-(2-Chloroethyl)-2,6-dimethylmorpholine
• CAS: 147847-86-7
• 化学式: C₈H₁₆ClNO
• 分子量: 177.674
• InChiKey: GSCDLDXSKMWJMV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(2-chloro-ethyl)-2,6-dimethyl-morpholine 在 sodium amide 、 甲苯 、 苯 作用下， 生成 6-(2,6-dimethyl-morpholino)-4,4-diphenyl-hexan-3-one
  参考文献：
  名称：

  Dupre et al., Journal of the Chemical Society, 1949, p. 500,505

  摘要：

  DOI：
• 作为产物：
  描述：

  二氯异丙醚 在 氯化亚砜 、 potassium carbonate 、 苯 作用下， 生成 4-(2-chloro-ethyl)-2,6-dimethyl-morpholine
  参考文献：
  名称：

  Dupre et al., Journal of the Chemical Society, 1949, p. 500,505

  摘要：

  DOI：

文献信息

• Pyridazino[3,4,5-<i>de</i>]phthalazines. II. Synthesis of nitrogen-substituted derivatives
  作者：John E. Francis、Karl J. Doebel、Paula M. Schutte、Ernst F. Bachmann、Robert E. Detlefsen

  DOI：10.1139/v82-180

  日期：1982.5.15

  The synthesis of a wide variety of 9-substituted-3-oxo-3H-2,9-dihydropyridazino[3,4,5-de]phthalazines (11) was achieved by treatment of 3-substituted-3,4-dihydro-4-oxophthalazine-5-carboxylic esters (10) with hydrazine hydrate. These esters were prepared from 3-hydroxyphthalide-7-carboxylic acid (7) by two different routes. Under basic conditions, alkylation of 3-oxo-3H-2,9-dihydropyridazino[3,4,5-de]phthalazine (1) gave 9-substituted products. These undergo further alkylation at the 2-position. Some of them were converted to 3-chloro, 3-thiono, and 3-hydrazino compounds by standard methods. Dehalogenation of selected 3-chloro compounds or desulphurization of 3-thiono derivatives gave 1-substituted-1H-pyridazino[3,4,5-de]phthalazines (22), some of which were also prepared by direct alkylation of the parent heterocycle 2 under basic conditions. However, treatment of 2 or its 1-methyl homologue with methyl iodide resulted in products in which nitrogen attached to carbon had been attacked rather than the 1- or 9-position. Treatment of the acid chloride of 3,4-dihydro-4-oxophthalazine-5-carboxylic acid with methyl hydrazine led to 2-methyl-3-oxo-3H-2,9-dihydropyridazino[3,4,5-de]phfhalazine (21a) which was purified by cyanoethylation at the 9-position, recrystallization, and hydrazinolysis of the cyanoethyl group. Biological testing revealed that many of the compounds lowered blood pressure in animal models but none had a sufficient therapeutic ratio of activity vs. side effects to warrant clinical trial.

  一种广泛的9-取代-3-氧代-3H-2,9-二氢吡啶并[3,4,5-de]邻苯二氮酮（11）的合成是通过将3-取代-3,4-二氢-4-氧代邻苯二酮-5-羧酸酯（10）与水合肼处理而实现的。这些酯是通过两种不同的途径从3-羟基邻苯二酮-7-羧酸（7）制备的。在碱性条件下，3-氧代-3H-2,9-二氢吡啶并[3,4,5-de]邻苯二酮（1）的烷基化产生了9-取代产物。这些产物在2-位进一步发生烷基化。其中一些经过标准方法转化为3-氯、3-硫代和3-肼基化合物。选择性去卤化3-氯化合物或去硫化3-硫代衍生物得到1-取代-1H-吡啶并[3,4,5-de]邻苯二氮酮（22），其中一些也是通过在碱性条件下直接烷基化母环2制备的。然而，用碘甲烷处理2或其1-甲基同分异构体的结果是氮连接到碳而不是1-位或9-位。用甲基肼处理3,4-二氢-4-氧代邻苯二酮-5-羧酸酰氯导致2-甲基-3-氧代-3H-2,9-二氢吡啶并[3,4,5-de]邻苯二氮酮（21a），通过在9-位进行氰基乙基化、再结晶和氰基乙基基团的肼解纯化。生物测试显示许多化合物在动物模型中降低了血压，但没有一个具有足够的活性与副作用之间的治疗比例，值得进行临床试验。
• Fungicidal 2-aryl-2-cyano-2-(heterocyclylalkyl)ethyl-1,2,4-triazoles
  申请人：Rohm and Haas Company

  公开号：US05240925A1

  公开（公告）日：1993-08-31

  This invention relates to 2-aryl-2-cyano-2-(heterocyclylalkyl)ethyl-1,2,4-triazoles of the formula ##STR1## wherein Ar is an optionally substituted aryl group, Het is an optionally substituted five or six membered saturated or unsaturated heterocyclic ring containing one, two or three heteroatoms selected from oxygen, nitrogen and sulfur, or is a bicyclic unsaturated ring system containing up to ten atoms including one heteroatom selected from oxygen, nitrogen and sulfur, R is hydrogen or alkyl, n is zero or an integer of at least one, and the agronomically acceptable enantiomorphs, geometric isomers, acid addition salts and metal salt complexes thereof.

  本发明涉及具有以下式子的2-芳基-2-氰基-2-(杂环基烷基)乙基-1,2,4-三唑：##STR1## 其中Ar是可选取的取代芳基基团，Het是可选取的含有氧、氮和硫的一个、两个或三个杂原子的五元或六元饱和或不饱和杂环环，或是一个含有最多十个原子，其中包括一个氧、氮或硫杂原子的双环不饱和环系统，R是氢或烷基，n为零或至少为一的整数，以及其农业上可接受的对映异构体、几何异构体、酸加成盐和金属盐络合物。
• Prodrugs of fumarates and their use in treating various diseases
  申请人：Alkermes Pharma Ireland Limited

  公开号：US10080733B2

  公开（公告）日：2018-09-25

  The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.

  本发明提供了式 (I) 化合物及其药物组合物。
• FRANCIS, J. E.;DOEBEL, K. J.;SCHUTTE, P. M.;BACHMANN, E. F.;DETLEFSEN, R.+, CAN. J. CHEM., 1982, 60, N 10, 1214-1232
  作者：FRANCIS, J. E.、DOEBEL, K. J.、SCHUTTE, P. M.、BACHMANN, E. F.、DETLEFSEN, R.+

  DOI：——

  日期：——
• US20140275048A1
  申请人：——

  公开号：——

  公开（公告）日：——